| Identification of pyrrolo [3′, 4’: 3, 4] cyclohepta [1, 2-d][1, 2] oxazoles as promising new candidates for the treatment of lymphomas M Barreca, V Spanò, R Rocca, R Bivacqua, G Gualtieri, MV Raimondi, ... European journal of medicinal chemistry 254, 115372, 2023 | 22 | 2023 |
| Histone deacetylase inhibitors impair glioblastoma cell motility and proliferation E Rampazzo, L Manfreda, S Bresolin, A Cani, E Mariotto, R Bortolozzi, ... Cancers 14 (8), 1897, 2022 | 14 | 2022 |
| Collagen VI sustains cell stemness and chemotherapy resistance in glioblastoma M Cescon, E Rampazzo, S Bresolin, F Da Ros, L Manfreda, A Cani, ... Cellular and Molecular Life Sciences 80 (8), 233, 2023 | 10 | 2023 |
| Design, synthesis and biological investigation of 2-anilino triazolopyrimidines as tubulin polymerization inhibitors with anticancer activities R Romagnoli, P Oliva, F Prencipe, S Manfredini, F Budassi, A Brancale, ... Pharmaceuticals 15 (8), 1031, 2022 | 7 | 2022 |
| Wnt signaling in brain tumors: A challenging therapeutic target L Manfreda, E Rampazzo, L Persano Biology 12 (5), 729, 2023 | 6 | 2023 |
| Identification of Homoharringtonine as a potent inhibitor of glioblastoma cell proliferation and migration E Porcù, F Maule, L Manfreda, E Mariotto, S Bresolin, A Cani, R Bortolozzi, ... Translational Research 251, 41-53, 2023 | 6 | 2023 |
| Surviving the hunger games: Metabolic reprogramming in medulloblastoma L Manfred, E Rampazzo, L Persano, G Viola, R Bortolozzi Biochemical Pharmacology, 115697, 2023 | 3 | 2023 |
| Molecular and functional profiling of chemotolerant cells unveils nucleoside metabolism-dependent vulnerabilities in medulloblastoma E Mariotto, E Rampazzo, R Bortolozzi, F Rruga, I Zeni, L Manfreda, ... Acta Neuropathologica Communications 11 (1), 183, 2023 | 2 | 2023 |
| METABOLIC REWIRING SUPPORT THE ONSET OF CHEMOTHERAPY RESISTANCE IN MEDULLOBLASTOMA R Bortolozzi, E Mariotto, E Rampazzo, L Manfreda, C Marchioro, F Rruga, ... Neuro-Oncology 24, 173-173, 2022 | 2 | 2022 |
| Design, synthesis, and biological investigation of selective human carbonic anhydrase II, IX, and XII inhibitors using 7-aryl/heteroaryl triazolopyrimidines bearing a … R Romagnoli, T De Ventura, S Manfredini, E Baldini, CT Supuran, ... Journal of Enzyme Inhibition and Medicinal Chemistry 38 (1), 2270180, 2023 | | 2023 |
| MULTI-OMICS INVESTIGATION OF MEDULLOBLASTOMA RESISTANT MODELS REVEALS FUNCTIONAL ASSOCIATION BETWEEN INTRACELLULAR REGULATORY NETWORKS AND DRUG SUSCEPTIBILITY E Mariotto, E Rampazzo, R Bortolozzi, F Rruga, L Manfreda, C Marchioro, ... NEURO-ONCOLOGY 24, 173-173, 2022 | | 2022 |
| Pembrolizumab in prima linea nel NSCLC: studio pilota in real practice all'Istituto Oncologico Veneto IRCCS per vrificare il rapporto fra tossicità ed esiti A Russi, L Faoro, V Casotto, L Manfreda, M Pesavento, N Realdon, ... VII Congresso Nazionale Sifact, 2019 | | 2019 |
